Literature DB >> 22791398

Cardiovascular disease and rheumatoid arthritis: an update.

Christina Charles-Schoeman1.   

Abstract

Patients with rheumatoid arthritis (RA) suffer significantly increased cardiovascular (CV) morbidity and mortality, when compared with the general population. Both traditional CV risk factors and high levels of systemic inflammation have been linked to the increased CV risk in RA patients, but significant uncertainty remains regarding the mechanisms through which these factors contribute to CV disease (CVD). In addition, ongoing questions remain regarding how best to identify RA patients at high risk for CVD and what primary and secondary prevention strategies are effective at influencing CV outcome. The present review summarizes recent research in this field.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22791398      PMCID: PMC3436948          DOI: 10.1007/s11926-012-0271-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  70 in total

1.  Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.

Authors:  Jesper Lindhardsen; Ole Ahlehoff; Gunnar Hilmar Gislason; Ole Rintek Madsen; Jonas Bjerring Olesen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  Ann Rheum Dis       Date:  2012-03-08       Impact factor: 19.103

2.  Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.

Authors:  Jeffrey R Curtis; Ani John; Onur Baser
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

3.  Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis.

Authors:  Christie M Bartels; Amy J H Kind; Carolyn T Thorpe; Christine M Everett; Rachel J Cook; Patrick E McBride; Maureen A Smith
Journal:  Semin Arthritis Rheum       Date:  2012-03-16       Impact factor: 5.532

4.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

Review 5.  HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

Authors:  M Navab; J A Berliner; G Subbanagounder; S Hama; A J Lusis; L W Castellani; S Reddy; D Shih; W Shi; A D Watson; B J Van Lenten; D Vora; A M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

6.  Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

Authors:  M Navab; S Y Hama; G M Anantharamaiah; K Hassan; G P Hough; A D Watson; S T Reddy; A Sevanian; G C Fonarow; A M Fogelman
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

7.  Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

Authors:  M Navab; S Y Hama; C J Cooke; G M Anantharamaiah; M Chaddha; L Jin; G Subbanagounder; K F Faull; S T Reddy; N E Miller; A M Fogelman
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

8.  Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis.

Authors:  Junji Watanabe; Christina Charles-Schoeman; Yunan Miao; David Elashoff; Yuen Yin Lee; George Katselis; Terry D Lee; Srinivasa T Reddy
Journal:  Arthritis Rheum       Date:  2012-01-09

9.  Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.

Authors:  S Wållberg-Jonsson; H Johansson; M L Ohman; S Rantapää-Dahlqvist
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

10.  Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.

Authors:  Jon T Giles; Justyna Fert-Bober; Jin Kyun Park; Clifton O Bingham; Felipe Andrade; Karen Fox-Talbot; Dimitrios Pappas; Antony Rosen; Jennifer van Eyk; Joan M Bathon; Marc K Halushka
Journal:  Arthritis Res Ther       Date:  2012-02-24       Impact factor: 5.156

View more
  14 in total

1.  Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.

Authors:  Iryna Voloshyna; Sony Modayil; Michael J Littlefield; Elise Belilos; Kristina Belostocki; Lois Bonetti; Gary Rosenblum; Steven E Carsons; Allison B Reiss
Journal:  Exp Biol Med (Maywood)       Date:  2013-09-02

2.  Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.

Authors:  Renli Teng; Mirjana Kujacic; Judith Hsia
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

3.  MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.

Authors:  J F Mendoza Rincón; A K Rodríguez Elias; J M Fragoso; G Vargas Alarcón; K Maldonado Murillo; M L Rivas Jiménez; R E Barbosa Cobos; S Jimenez Morales; G Lugo Zamudio; C Tovilla Zárate; J Ramírez Bello
Journal:  Rheumatol Int       Date:  2015-09-08       Impact factor: 2.631

Review 4.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

5.  Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.

Authors:  Jason Foo; Chaienna Morel; Martin Bergman; Christoph Baerwald; José Manuel Rodriguez-Heredia; Alexander Marshall; Carlos Polanco-Sánchez; Roelien Postema
Journal:  Rheumatol Int       Date:  2019-06-25       Impact factor: 2.631

6.  Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.

Authors:  Amir A Razmjou; Jennifer M Wang; Ani Shahbazian; Srinivasa Reddy; Christina Charles-Schoeman
Journal:  Clin Rheumatol       Date:  2022-09-22       Impact factor: 3.650

7.  Comorbidities, intensity, frequency and duration of pain, daily functioning and health care seeking in local, regional, and widespread pain - a descriptive population-based survey (SwePain).

Authors:  Anna Grimby-Ekman; Björn Gerdle; Jonas Björk; Britt Larsson
Journal:  BMC Musculoskelet Disord       Date:  2015-07-24       Impact factor: 2.362

8.  The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis.

Authors:  James Doonan; Anuradha Tarafdar; Miguel A Pineda; Felicity E Lumb; Jenny Crowe; Aneesah M Khan; Paul A Hoskisson; Margaret M Harnett; William Harnett
Journal:  Nat Commun       Date:  2019-04-05       Impact factor: 14.919

9.  Determinants of brachial-ankle pulse wave velocity in Chinese patients with rheumatoid arthritis.

Authors:  Ping Li; Cheng-Xun Han; Cui-Li Ma; Jia-Long Guo; Bo Liu; Juan Du; Li-Qi Bi
Journal:  Clin Dev Immunol       Date:  2013-07-31

Review 10.  Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Authors:  Mir Sohail Fazeli; Vadim Khaychuk; Keith Wittstock; Boris Breznen; Grace Crocket; Mir-Masoud Pourrahmat; Leticia Ferri
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.